Velarion Records
Free. Unsubscribe any time.

GYRE THERAPEUTICS, INC. (GYRE)

GYRE THERAPEUTICS, INC. filed 33 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 71 transactions and 122,698 shares. 33 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in GYRE THERAPEUTICS, INC. 71

Adoption dates in GYRE THERAPEUTICS, INC. 2

Results prints in GYRE THERAPEUTICS, INC. 0

Trades before a print in GYRE THERAPEUTICS, INC. 0

Interval to GYRE THERAPEUTICS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates GYRE THERAPEUTICS, INC. states

Filing text: “10b5-1 trading plan adopted on September 13, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.